glp 1 mash approval Wegovy becomes first GLP-1RA to gain FDA glp 1 approved for nash

However, multiple recent well-conducted studies and meta-analyses reported a risk of heart disease and stroke that is equivalent if not higher in women compared with men who have diabetes

This is a different regulatory category from prescription GLP-1 drugs such as Wegovy and Mounjaro, which are MHRA-licensed medicines that have undergone full clinical assessment

Gluten in Medicine: Vitamins and Supplements

A phase 2b study in patients with NASH (stage 1-3) is evaluating the efficacy of 72 weeks of emiricasan 10 or 100 mg (ENCORE-NF, NCT02686762)

Understanding how these medications work is an important first step toward choosing the right approach